[HTML][HTML] Analysis of lncRNA, miRNA and mRNA-associated ceRNA networks and identification of potential drug targets for drug-resistant non-small cell lung cancer

X Kong, S Hu, Y Yuan, Y Du, Z Zhu, Z Song, S Lu… - Journal of …, 2020 - ncbi.nlm.nih.gov
Background: Drug resistance to chemotherapeutic drugs or targeted medicines is an
obstacle encountered in the treatment of non-small-cell lung cancer (NSCLC). However, the …

[HTML][HTML] LncRNA XIST acts as a MicroRNA-520 sponge to regulate the Cisplatin resistance in NSCLC cells by mediating BAX through CeRNA network

TT Liu, R Li, X Liu, XJ Zhou, C Huo, JP Li… - International journal of …, 2021 - ncbi.nlm.nih.gov
Background: In recent years, LncRNA acts as a member of competing endogenous RNA
(ceRNA), playing an important role in drug resistance of lung cancer. The aim of this study …

[HTML][HTML] Construction of ceRNA network to identify the lncRNA and mRNA related to non-small cell lung cancer

K Xiao, Y Wang, L Zhou, J Wang, Y Wang, D Tong… - PLoS …, 2021 - journals.plos.org
Background Non-small cell lung cancer (NSCLC) harms human health, but its pathogenesis
remains unclear. We wish to provide more molecular therapeutic targets for NSCLC …

Construction of a competing endogenous RNA network using differentially expressed lncRNAs, miRNAs and mRNAs in non-small cell lung cancer

XW Wang, QQ Guo, Y Wei, KM Ren… - Oncology …, 2019 - spandidos-publications.com
The competing endogenous RNA (ceRNA) network is crucial for the development and
progression of tumors, including non-small cell lung cancer (NSCLC). However, what type of …

Identification of primary and metastatic lung cancer-related lncRNAs and potential targeted drugs based on ceRNA network

S Dong, C Wu, C Song, B Qi, L Liu, Y Xu - Frontiers in oncology, 2021 - frontiersin.org
Lung cancer metastasis is the leading cause of poor prognosis and death for patients. Long
noncoding RNAs (lncRNAs) have been validated the close correlation with lung cancer …

[HTML][HTML] The construction and analysis of the aberrant lncRNA-miRNA-mRNA network in non-small cell lung cancer

X Wang, H Yin, L Zhang, D Zheng, Y Yang… - Journal of thoracic …, 2019 - ncbi.nlm.nih.gov
Background Non-small cell lung cancer (NSCLC) is the most common cancer and the
pathogenesis remain unclear. According to the competing endogenous RNA (ceRNA) …

Long non-coding RNA in drug resistance of non-small cell lung cancer: a mini review

R Sun, R Wang, S Chang, K Li, R Sun… - Frontiers in …, 2019 - frontiersin.org
Lung cancer is one of main causes of cancer mortality and 83% of lung cancer cases are
classified as non-small cell lung cancer (NSCLC). Patients with NSCLC usually have a poor …

Identification of lncRNA, miRNA and mRNA expression profiles and ceRNA Networks in small cell lung cancer

C Zhang, Y Zhou, B Zhang, Z Sheng, N Sun, B Yuan… - BMC genomics, 2023 - Springer
Background Small cell lung cancer (SCLC) is a highly lethal malignant tumor. It accounts for
approximately 15% of newly diagnosed lung cancers. Long non-coding RNAs (lncRNAs) …

Integrated analysis of lncRNA-miRNA-mRNA ceRNA network identified lncRNA EPB41L4A-AS1 as a potential biomarker in non-small cell lung cancer

M Wang, S Zheng, X Li, Y Ding, M Zhang, L Lin… - Frontiers in …, 2020 - frontiersin.org
Background Recent evidence has indicated that long non-coding RNAs (lncRNAs) can
function as competing endogenous RNAs (ceRNAs) to modulate mRNAs expression by …

[HTML][HTML] The functional role of long non-coding RNAs and their underlying mechanisms in drug resistance of non-small cell lung cancer

H Zhou, B Feng, M Abudoureyimu, Y Lai, X Lin, C Tian… - Life sciences, 2020 - Elsevier
Background Non-small cell lung cancer (NSCLC) is the most commonly diagnosed solid
cancer and the main origin of cancer-related deaths worldwide. Current strategies to treat …